International Cannabis Weekly: 447

THE US OFFICIALLY RESCHEDULES CANNABIS, PARTLY…

For many, last week’s rescheduling announcement threw a spanner in the works. The US medical cannabis market, for now the only market to be impacted by rescheduling directly, is far smaller and, as such, much less of a priority for many operators.

READ MORE  »

DEA’S SCHEDULE III CANNABIS ORDER: A FREE-FOR-ALL FOR TELEHEALTH PLATFORMS?

READ MORE »

‘THOUGHTFUL, PRUDENT, PATIENT’ – WHY VILLAGE FARMS IS SITTING OUT THE M&A RUSH

READ MORE »

• Cannabis rescheduling appears to accelerate the latest wave of European M&A activity.
• Bavarian court acquits hemp trader as Germany’s intoxication clause faces scrutiny.
• Medical cannabis shows clear results for 3,500 patients as opioid alternative.
• Industry publishes new guidance for medical cannabis patients travelling internationally.
• Ireland’s medical cannabis programme continues to stagnate despite patient need.
• Portugal’s hemp sector gains two new associations representing industry operators.
• German cannabis offences decline following decriminalisation and wider legal reform.
• Jersey reshapes European cannabis supply chains with production exceeding Colombia.
• Bosnia and Herzegovina moves from decision to cannabis therapy implementation.
• Curaleaf completes buyout of Germany’s Four 20 Pharma.

USE ICW15 FOR 15% OFF »

• DEA Schedule III cannabis order is raising major questions for telehealth platforms.
• Indiana governor says cannabis legalisation is more likely after federal rescheduling.
• Hoosiers is poised to spend an estimated $1.8 billion a year on cannabis, according to reports.
• Maryland governor signs bill protecting off-duty medical cannabis use for firefighters.
• Missouri cannabis cultivators have filed class action lawsuit against Good Day Farm.
• Virginia lawmakers are debating plans to create a regulated legal cannabis marketplace.
• Federal judge to decide whether Medicare can distribute hemp-based marijuana products.
• Arkansas medical cannabis businesses prepare for changes after federal reclassification.
• Florida spars with Trulieve over alleged pollution at one of their cannabis cultivation site.

• Canadian cannabis sales continued to advance in February despite market pressures.
• Aurora Cannabis expands its medical cannabis portfolio across key global markets.
• Multipacks are reshaping Canada’s cannabis edibles market as consumer habits evolve.
• MEXC reports latest cannabis market developments following renewed investor attention.
• Cannabis retailers receive medical expert advice on supporting consumers responsibly.
• Jushi Holdings announces proposed continuance from British Columbia to Nevada.
• MediPharm Labs positioned to serve growing US pharmaceutical and research demand.

• Bahamas Cannabis Authority says licensing platform for businesses is now complete.
• Misiopharma and Biofábrica announce merger to strengthen cannabis industry capabilities.
• Ganja Growers and Producers Association of Jamaica welcomes US cannabis reclassification.
• Brazil and Argentina strengthen medicinal cannabis and industrial hemp working networks.
• Ecuador electoral authority halts cannabis regulation proposal over insufficient signatures.

• LGP and Cannatrek both expect the companies’ proposed merger to complete on June 1.
• China halves bast fibre imports, which signals some volatility in global hemp markets.
• Nepal urged to regulate cannabis cultivation before issuing cultivation licences.
• Agential Cannabis 2026 is taking shape as APAC medicinal cannabis marketplace.
• New Zealand grower body has signalled growth phase for medicinal cannabis industry.

• Labat Africa has signaled strong revenue surge despite decline in earnings performance.
• Zimbabwe’s hemp industry has shifted from promise to strategic market positioning